Cargando…

Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis

In this study, we explore the role of nuclear survivin in maintaining the effector phenotype of IFNγ-producing T cells acting through the transcriptional control of glucose utilization. High expression of survivin in CD4(+)T cells was associated with IFNγ-dependent phenotype and anaerobic glycolysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Erlandsson, Malin C., Andersson, Karin M.E., Oparina, Nina Y., Chandrasekaran, Venkataragavan, Saghy, Tibor, Damdimopoulos, Anastasios, Garcia-Bonete, Maria-Jose, Einbeigi, Zakaria, Silfverswärd, Sofia T., Pekna, Marcela, Katona, Gergely, Bokarewa, Maria I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678772/
https://www.ncbi.nlm.nih.gov/pubmed/36425763
http://dx.doi.org/10.1016/j.isci.2022.105526
_version_ 1784834060898533376
author Erlandsson, Malin C.
Andersson, Karin M.E.
Oparina, Nina Y.
Chandrasekaran, Venkataragavan
Saghy, Tibor
Damdimopoulos, Anastasios
Garcia-Bonete, Maria-Jose
Einbeigi, Zakaria
Silfverswärd, Sofia T.
Pekna, Marcela
Katona, Gergely
Bokarewa, Maria I.
author_facet Erlandsson, Malin C.
Andersson, Karin M.E.
Oparina, Nina Y.
Chandrasekaran, Venkataragavan
Saghy, Tibor
Damdimopoulos, Anastasios
Garcia-Bonete, Maria-Jose
Einbeigi, Zakaria
Silfverswärd, Sofia T.
Pekna, Marcela
Katona, Gergely
Bokarewa, Maria I.
author_sort Erlandsson, Malin C.
collection PubMed
description In this study, we explore the role of nuclear survivin in maintaining the effector phenotype of IFNγ-producing T cells acting through the transcriptional control of glucose utilization. High expression of survivin in CD4(+)T cells was associated with IFNγ-dependent phenotype and anaerobic glycolysis. Transcriptome of CD4(+) cells and sequencing of survivin-bound chromatin showed that nuclear survivin had a genome-wide and motif-specific binding to regulatory regions of the genes controlling cell metabolism. Survivin coprecipitates with transcription factors IRF1 and SMAD3, which repressed the transcription of the metabolic check-point enzyme phosphofructokinase 2 gene PFKFB3 and promoted anaerobic glycolysis. Combining transcriptome analyses of CD4(+) cells and functional studies in glucose metabolism, we demonstrated that the inhibition of survivin reverted PFKFB3 production, inhibited glucose uptake, and reduces interferon effects in CD4(+) cells. These results present a survivin-dependent mechanism in coordinating the metabolic adaptation of CD4(+)T cells and propose an attractive strategy to counteract IFNγ-dependent inflammation in autoimmunity.
format Online
Article
Text
id pubmed-9678772
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96787722022-11-23 Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis Erlandsson, Malin C. Andersson, Karin M.E. Oparina, Nina Y. Chandrasekaran, Venkataragavan Saghy, Tibor Damdimopoulos, Anastasios Garcia-Bonete, Maria-Jose Einbeigi, Zakaria Silfverswärd, Sofia T. Pekna, Marcela Katona, Gergely Bokarewa, Maria I. iScience Article In this study, we explore the role of nuclear survivin in maintaining the effector phenotype of IFNγ-producing T cells acting through the transcriptional control of glucose utilization. High expression of survivin in CD4(+)T cells was associated with IFNγ-dependent phenotype and anaerobic glycolysis. Transcriptome of CD4(+) cells and sequencing of survivin-bound chromatin showed that nuclear survivin had a genome-wide and motif-specific binding to regulatory regions of the genes controlling cell metabolism. Survivin coprecipitates with transcription factors IRF1 and SMAD3, which repressed the transcription of the metabolic check-point enzyme phosphofructokinase 2 gene PFKFB3 and promoted anaerobic glycolysis. Combining transcriptome analyses of CD4(+) cells and functional studies in glucose metabolism, we demonstrated that the inhibition of survivin reverted PFKFB3 production, inhibited glucose uptake, and reduces interferon effects in CD4(+) cells. These results present a survivin-dependent mechanism in coordinating the metabolic adaptation of CD4(+)T cells and propose an attractive strategy to counteract IFNγ-dependent inflammation in autoimmunity. Elsevier 2022-11-07 /pmc/articles/PMC9678772/ /pubmed/36425763 http://dx.doi.org/10.1016/j.isci.2022.105526 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Erlandsson, Malin C.
Andersson, Karin M.E.
Oparina, Nina Y.
Chandrasekaran, Venkataragavan
Saghy, Tibor
Damdimopoulos, Anastasios
Garcia-Bonete, Maria-Jose
Einbeigi, Zakaria
Silfverswärd, Sofia T.
Pekna, Marcela
Katona, Gergely
Bokarewa, Maria I.
Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
title Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
title_full Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
title_fullStr Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
title_full_unstemmed Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
title_short Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
title_sort survivin promotes a glycolytic switch in cd4(+) t cells by suppressing the transcription of pfkfb3 in rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678772/
https://www.ncbi.nlm.nih.gov/pubmed/36425763
http://dx.doi.org/10.1016/j.isci.2022.105526
work_keys_str_mv AT erlandssonmalinc survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT anderssonkarinme survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT oparinaninay survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT chandrasekaranvenkataragavan survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT saghytibor survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT damdimopoulosanastasios survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT garciabonetemariajose survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT einbeigizakaria survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT silfverswardsofiat survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT peknamarcela survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT katonagergely survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis
AT bokarewamariai survivinpromotesaglycolyticswitchincd4tcellsbysuppressingthetranscriptionofpfkfb3inrheumatoidarthritis